Cannara Biotech Inc. (TSXV:LOVE)

Canada flag Canada · Delayed Price · Currency is CAD
1.900
-0.050 (-2.56%)
Aug 8, 2025, 3:59 PM EDT
-2.56%
Market Cap173.72M
Revenue (ttm)101.87M
Net Income (ttm)15.52M
Shares Out91.43M
EPS (ttm)0.17
PE Ratio11.19
Forward PE19.00
Dividendn/a
Ex-Dividend Daten/a
Volume106,072
Average Volume117,912
Open1.930
Previous Close1.950
Day's Range1.870 - 1.950
52-Week Range0.570 - 1.990
Beta0.26
RSI61.88
Earnings DateJul 18, 2025

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. [Read more]

Sector Healthcare
Founded 2017
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol LOVE
Full Company Profile

Financial Performance

In 2024, Cannara Biotech's revenue was 81.75 million, an increase of 42.77% compared to the previous year's 57.26 million. Earnings were 6.44 million, a decrease of -7.30%.

Financial Statements

News

There is no news available yet.